Put companies on watchlist
Redcare Pharmacy N.V.
ISIN: NL0012044747
WKN: A2AR94
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Redcare Pharmacy N.V. · ISIN: NL0012044747 · EQS - Company News (113 News)
Country: Netherlands · Primary market: Netherlands · EQS NID: 1655053
13 June 2023 09:32AM

Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.


EQS-News: Redcare Pharmacy N.V. / Key word(s): Strategic Company Decision
Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.

13.06.2023 / 09:32 CET/CEST
The issuer is solely responsible for the content of this announcement.


Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leading
e-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official.

With today’s event, Europe’s largest one-stop pharmacy takes another step in its rebranding, officially launching the new corporate brand Redcare Pharmacy N.V. The change of the ticker symbol from SAE to RDC was completed during an opening bell ceremony at the Frankfurt Stock Exchange, attended by the Executive Management Board, representatives of the Supervisory Board and other senior management members.

Redcare Pharmacy is more than an e-pharmacy, more than just a webshop. The brand itself stands for care, innovative solutions and services dedicated to the health of customers, employees and other stakeholders. The new name reflects the health care aspect as well as the internationalisation of the e-pharmacy that is currently active in seven countries. Red picks up on the pharmacy colour that is used in the main markets; Pharmacy represents the core business. The new name applies exclusively to the corporate brand. The names of the webshops, subsidiaries and other entities will stay the same.

Theresa Holler, Chief Operating Officer and responsible pharmacist, comments, “Today marks a significant milestone in our company’s history. By changing our name to Redcare Pharmacy, we want to emphasise our focus on providing comprehensive care and guidance for our customers in all aspects of their health. We are proud to be the one-stop pharmacy of the future. Actually, Redcare Pharmacy signifies the beginning of a new, exciting era for us.”

An additional milestone to further emphasise this next chapter for the company was the simultaneous launch of the new corporate website under the new name, design and logo. By presenting itself as Redcare Pharmacy, the company reflects its clear focus on people, to guide and support them on their way to better health.

The new corporate website can be found at www.redcare-pharmacy.com.

 

About Redcare Pharmacy

Originally founded in 2001, Redcare Pharmacy (formerly known as Shop Apotheke Europe) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven.

As the one-stop pharmacy of the future, Redcare Pharmacy offers almost 10 million active customers a wide range of more than 150,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany.

Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.

Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. Currently part of the SDAX, as of 19 June 2023, the company will be a member of the MDAX selection index.



13.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1655053

 
End of News EQS News Service

1655053  13.06.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1655053&application_name=news&site_id=boersengefluester
Visual performance / price development - Redcare Pharmacy N.V.
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.